SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-16-112632
Filing Date
2016-04-04
Accepted
2016-04-04 20:33:16
Documents
1
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3778
  Complete submission text file 0001209191-16-112632.txt   5182
Mailing Address C/O STEMLINE THERAPEUTICS, INC. 750 LEXINGTON AVENUE, 6TH FLOOR NEW YORK NY 10022
Business Address
HALL STEPHEN P (Reporting) CIK: 0001243200 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33827 | Film No.: 161552817

Mailing Address 880 WINTER STREET SUITE 210 WALTHAM MA 02451
Business Address 880 WINTER STREET SUITE 210 WALTHAM MA 02451 781-890-1199
BG Medicine, Inc. (Issuer) CIK: 0001407038 (see all company filings)

IRS No.: 043506204 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences